Understanding Hepatitis‍ C: A Turning Point in Treatment

Recent therapeutic advancements have dramatically changed the landscape of Hepatitis C treatment. New direct-acting antiviral ⁢drugs (DAA) now offer a definitive cure in over ​90% of cases, significantly reducing the risk of serious liver complications like cirrhosis and liver cancer. This success is driving a push for widespread testing.

Because of this very reason, the Centers for Disease Control and Prevention (CDC) recommends a one-time Hepatitis C screening for all adults aged 18 years and older⁢ . Individuals with risk ‌factors‌ -⁣ including those who have ever injected drugs, received​ a ⁤blood transfusion before 1992, ⁤or were born to a mother with Hepatitis‍ C – should undergo ⁣regular testing .

The Milan Polyclinic’s Role in Advanced Liver care

The Milan Polyclinic is a leading institution in the diagnosis and treatment of Hepatitis​ C ⁣and related liver diseases. ‌They​ offer integrated diagnostic pathways and comprehensive treatment plans,⁢ ensuring patients⁣ receive the most up-to-date care. Further information about⁤ the Milan Polyclinic’s hepatology department can be found ⁣on their official website .

MASLD: A Silent Epidemic

Alongside the progress in Hepatitis C treatment, a new global ​health emergency is emerging: Metabolic Associated Steatotic Liver Disease (MASLD), commonly known as fatty liver ‍disease. This condition involves the ‌accumulation of fat in the liver, even in the absence of ‍notable alcohol consumption.

MASLD is frequently enough asymptomatic in its early stages, making it a “silent” threat. ‍ Patients may experience vague symptoms like ⁣fatigue, a feeling of fullness, ‍or mild ​discomfort in⁤ the upper⁣ right abdomen. Diagnosis relies on evaluating metabolic risk factors – obesity, hypertension, diabetes, and dyslipidemia – alongside imaging tests like liver ultrasound .

While progression to severe conditions like cirrhosis or hepatocellular carcinoma⁢ is relatively uncommon, MASLD significantly increases ⁤the risk of cardiovascular events (heart attack, heart failure), ​chronic kidney disease, and certain cancers (colon, breast) . Its⁤ systemic nature demands a holistic medical approach.

MASLD Risk Factors and Prevalence

The prevalence of MASLD is ‍rising globally, closely linked to the increasing rates of obesity and metabolic syndrome.Here’s a breakdown of key risk factors: